Empowering life sciences and diagnostics
Tecan is a leading global provider of automated laboratory instruments and solutions. Our systems and components help people working in clinical diagnostics, basic and translational research and drug discovery bring their science to life.
In particular, we develop, produce, market and support automated workflow solutions that empower laboratories to achieve more. Our Cavro branded instrument components are chosen by leading instrumentation suppliers across multiple disciplines.
Always there for our clients
We work side by side with a range of clients, including diagnostic laboratories, pharmaceutical and biotechnology companies and university research centers. Our expertise extends to developing and manufacturing OEM instruments and components, marketed by our partner companies. Whatever the project – large or small, simple or complex – helping our clients to achieve their goals comes first.
Changing the way labs work, worldwide
We hold a leading position in all the sectors we work in and have changed the way things are done in research and development labs around the world. In diagnostics, for instance, we have raised the bar when it comes to the reproducibility and throughput of testing.
In under four decades Tecan has grown from a Swiss family business to a brand that is well established on the global stage of life sciences. From pioneering days on a farm to the leading role our business assumes today – empowering research, diagnostics and many applied markets around the world.
Tecan is a leading global provider of automated laboratory instruments and solutions. Our systems and components help people working in clinical diagnostics, basic and translational research and drug discovery bring their science to life.
In particular, we develop, produce, market and support automated workflow solutions that empower laboratories to achieve more. Our Cavro branded instrument components are chosen by leading instrumentation suppliers across multiple disciplines.
Always there for our clients
We work side by side with a range of clients, including diagnostic laboratories, pharmaceutical and biotechnology companies and university research centers. Our expertise extends to developing and manufacturing OEM instruments and components, marketed by our partner companies. Whatever the project – large or small, simple or complex – helping our clients to achieve their goals comes first.
Changing the way labs work, worldwide
We hold a leading position in all the sectors we work in and have changed the way things are done in research and development labs around the world. In diagnostics, for instance, we have raised the bar when it comes to the reproducibility and throughput of testing.
In under four decades Tecan has grown from a Swiss family business to a brand that is well established on the global stage of life sciences. From pioneering days on a farm to the leading role our business assumes today – empowering research, diagnostics and many applied markets around the world.
Location: Switzerland, Zurich, Männedorf
Employees: 1001-5000
Phone: +41 44 922 81 11
Founded date: 1980
Mentions in press and media 31
| Date | Title | Description |
| 11.09.2025 | CUTISS Secures €57.9M, Propels Next-Gen Skin Regeneration | CUTISS secured €57.9M in Series C funding, propelling its advanced regenerative skin therapies forward. This significant capital boost supports denovoSkin, a bioengineered, personalized skin graft, through crucial Phase 3 clinical trials fo... |
| 11.09.2025 | CUTISS: CHF 56 Million Secured For Advancing Personalized Skin Therapy | CUTISS, a Swiss biotech company specializing in regenerative medicine, has closed a CHF 56 million Series C funding round, bringing its total capital raised to over CHF 125 million. The funding will support the continued development and com... |
| 10.09.2025 | CUTISS secures €57.9M Series C to advance regenerative skin therapies | Today CUTISS, a late-stage clinical TechBio at the forefront of tissue therapeutics and regenerative medicine, has announced the closing of its Series C round for €57.9 million (CHF 56M) with existing and new investors, bringing total funds... |
| 10.09.2025 | CUTISS raises additional CHF 31 million to support ongoing Phase 3 trials | CUTISS’ personalized, bioengineered skin graft denovoSkin is designed for patients undergoing skin surgery for burns, reconstructive and plastic procedures. Long-term follow-ups to date have shown that it drastically spares donor sites, ma... |
| 14.08.2025 | Four startups welcome new leaders to accelerate growth | Effective this month, Woody Schoch is the new CEO at Alivion, the developer of a science-backed solution, Nutrion, a precise breath analyzer to measure the current status of fat burning. With a simple breath, the device analyses specific b... |
| 06.08.2025 | +++ Holy +++ Labforward +++ LAP Coffee +++ REWE +++ Start-up Lounge +++ Food +++ | Was gibt’s Neues? In unserem #StartupTicker liefern wir eine kompakte Übersicht über die wichtigsten Startup-Nachrichten des Tages (Mittwoch, 6. August). #STARTUPLAND SAVE THE DATE: Am 5. November findet unsere zweite STARTUPLAND statt. Es ... |
| 17.04.2025 | Medtechs expand their global footprint with key partners | Swiss Medtech startup, b-rayZ, a leading provider of AI-driven breast imaging solutions, has found a partner in France. Together with Medecom, a company with over 25 years of expertise in digital mammography software solutions, this strate... |
| 03.04.2025 | Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits | Männedorf, Switzerland, April 3, 2025 – Tecan Group (SIX Swiss Exchange: TECN), announces an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences ... |
| 12.03.2024 | Tecan reports solid underlying sales growth and an increase in profitability and net profit for full year 2023 | - |
| 05.03.2024 | Tecan schedules conference call on March 12 to discuss Full-Year 2023 Financial Results | - |
Show more